Scientific Industries Inc (SCND) stock
SCNDOTCLaboratory Analytical InstrumentsFiscal year ends December 31
$0.68+0.00 (0.00%)
Close on Oct 19, 2026Market cap $8.16MP/E –Yield –
Scientific Industries r&d expenses
Research and development expenses are spending on new products and technology.
Scientific Industries's R&D Expenses for the twelve months ending Sep 30, 2026 was $2.68M, down 7.8% year over year. For fiscal 2025 it was $2.49M, down 14.2% from the year before. Over ten years it grew 19.3% a year on average. The highest annual figure on record is $2.90M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.49M | -14.2% |
| FY2024 | Dec 31, 2024 | $2.90M | +0.9% |
| FY2022 | Jun 30, 2022 | $2.87M | +76.9% |
| FY2021 | Jun 30, 2021 | $1.62M | +42.5% |
| FY2020 | Jun 30, 2020 | $1.14M | +114.8% |
| FY2019 | Jun 30, 2019 | $530.50K | +1.8% |
| FY2018 | Jun 30, 2018 | $520.90K | +19.1% |
| FY2017 | Jun 30, 2017 | $437.50K | +25.4% |
| FY2016 | Jun 30, 2016 | $349.00K | -11.0% |
| FY2015 | Jun 30, 2015 | $392.20K | -8.1% |
| FY2014 | Jun 30, 2014 | $426.70K | -5.3% |
| FY2013 | Jun 30, 2013 | $450.50K | +19.8% |
| FY2012 | Jun 30, 2012 | $375.90K | +15.9% |
| FY2011 | Jun 30, 2011 | $324.40K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $662.20K | +6.6% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $694.50K | +2.6% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $703.70K | +7.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $616.80K | -35.2% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $621.40K | -3.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $677.10K | +1.7% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $652.00K | -8.3% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $951.90K | +30.0% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $644.00K | +3.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $666.00K | -24.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $710.70K | +11.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $732.00K | +22.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $624.50K | +38.8% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $880.30K | +167.0% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $636.50K | +160.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $599.80K | +74.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $450.00K | +50.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $329.70K | +26.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $244.30K | +3.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $344.40K | +88.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $298.90K | +147.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $260.00K | +137.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $236.60K | +101.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $182.90K | +29.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $120.90K | +2.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $109.40K | -17.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $117.40K | -9.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $141.20K | +37.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $117.70K | +3.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $132.90K | +26.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $129.10K | +11.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $103.00K | +19.8% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $114.10K | +22.2% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $105.00K | +24.9% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $115.40K | +35.1% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $86.00K | +15.4% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $93.40K | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $84.10K | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $85.40K | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $74.50K | – |
See a number that looks wrong?